129 related articles for article (PubMed ID: 7660893)
41. Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction.
Swain JL; Hines JJ; Sabina RL; Harbury OL; Holmes EW
J Clin Invest; 1984 Oct; 74(4):1422-7. PubMed ID: 6480832
[TBL] [Abstract][Full Text] [Related]
42. Two purine biosynthetic enzymes that are required for cadmium tolerance in Schizosaccharomyces pombe utilize cysteine sulfinate in vitro.
Juang RH; McCue KF; Ow DW
Arch Biochem Biophys; 1993 Aug; 304(2):392-401. PubMed ID: 8346915
[TBL] [Abstract][Full Text] [Related]
43. Purine Salvage Pathway in Mycobacterium tuberculosis.
Ducati RG; Breda A; Basso LA; Santos DS
Curr Med Chem; 2011; 18(9):1258-75. PubMed ID: 21366536
[TBL] [Abstract][Full Text] [Related]
44. Fumaric acid production by Torulopsis glabrata: engineering the urea cycle and the purine nucleotide cycle.
Chen X; Wu J; Song W; Zhang L; Wang H; Liu L
Biotechnol Bioeng; 2015 Jan; 112(1):156-67. PubMed ID: 25060134
[TBL] [Abstract][Full Text] [Related]
45. [The second half of de novo synthetic pathway of IMP and conversion of IMP to AMP].
Oka J
Nihon Rinsho; 2003 Jan; 61 Suppl 1():52-8. PubMed ID: 12629690
[No Abstract] [Full Text] [Related]
46. Increases in purine excretion and rate of synthesis by drugs inhibiting IMP dehydrogenase or adenylosuccinate synthetase activities.
Willis RC; Seegmiller JE
Adv Exp Med Biol; 1979; 122B():237-41. PubMed ID: 44644
[No Abstract] [Full Text] [Related]
47. Ecto-5'-nucleotidase activity in lymphocytes from healthy and leukemia patients.
Agostiñho AB; Rosi F; Carlucci F; Pagani R; Pizzichini M; Marinello E; Galieni P; Dispensa E; Leoncini R
Adv Exp Med Biol; 1994; 370():227-30. PubMed ID: 7660895
[No Abstract] [Full Text] [Related]
48. Purine nucleotide content in leukocytes from patients with B-chronic lymphocytic leukemia.
Pagani R; Carlucci F; Consolmagno E; Dispensa E; Galieni P; Leoncini R; Pizzichini M; Tabucchi A
Biochem Soc Trans; 1993 Nov; 21(4):486S. PubMed ID: 8132053
[No Abstract] [Full Text] [Related]
49. Endo-5'-nucleotidase activity in lymphocytes from healthy subjects and leukemia patients.
Rosi F; Agostiñho AB; Tabucchi A; Pagani R; Pizzichini M; Marinello E; Leoncini R; Galieni P; Dispensa E
Adv Exp Med Biol; 1994; 370():231-5. PubMed ID: 7660897
[No Abstract] [Full Text] [Related]
50. [Enzymes of purine nucleotide metabolism as biochemical markers of the differentiation of normal and leukemic cells (review of the literature)].
Filanovskaia LI; Blinov MN
Vopr Med Khim; 1986; 32(6):10-7. PubMed ID: 3544486
[No Abstract] [Full Text] [Related]
51. De novo purine nucleotide synthesis in total peripheral blood lymphocytes from patients with B-chronic lymphocytic leukemia (B-CLL).
Egidio D; Carlucci F; Consolmagno E; Galieni P; Leoncini R; Pizzichini M; Tabucchi A; Pagani R
Biochem Soc Trans; 1994 May; 22(2):241S. PubMed ID: 7772107
[No Abstract] [Full Text] [Related]
52. [Enzymes of purine nucleotide catabolism in lymphocytes in normal states and in chronic lymphoid leukemia].
Filanovskaia LI; Vartanian NL; Togo AV; Samuskevich IG; Blinov MN
Vopr Med Khim; 1985; 31(3):48-53. PubMed ID: 2992163
[TBL] [Abstract][Full Text] [Related]
53. Uric acid synthesis by rat liver supernatants from purine bases, nucleosides and nucleotides. Effect of allopurinol.
Bleisch S; Sillero MA; Torrecilla A; Sillero A
Cell Biochem Funct; 1994 Dec; 12(4):237-45. PubMed ID: 7834812
[TBL] [Abstract][Full Text] [Related]
54. Purine nucleotide content in the leukocytes of leukemia patients.
Carlucci F; Tabucchi A; Consolmagno E; Dispensa E; Galieni P; Pagani R; Pizzichini M; Leoncini R; Marinello E
Adv Exp Med Biol; 1994; 370():237-41. PubMed ID: 7660898
[No Abstract] [Full Text] [Related]
55. A 57-gene expression signature in B-cell chronic lymphocytic leukemia.
Carlucci F; Marinello E; Tommassini V; Pisano B; Rosi F; Tabucchi A
Biomed Pharmacother; 2009 Nov; 63(9):663-71. PubMed ID: 19278812
[TBL] [Abstract][Full Text] [Related]
56. The purine nucleotide cycle and its molecular defects.
Van den Berghe G; Bontemps F; Vincent MF; Van den Bergh F
Prog Neurobiol; 1992 Nov; 39(5):547-61. PubMed ID: 1529104
[TBL] [Abstract][Full Text] [Related]
57. Isotope exchange at equilibrium studies with rat muscle adenylosuccinate synthetase.
Cooper BF; Fromm HJ; Rudolph FB
Biochemistry; 1986 Nov; 25(23):7323-7. PubMed ID: 3542024
[TBL] [Abstract][Full Text] [Related]
58. Regulation of purine metabolism: a comparative study of the kinetic properties of adenylosuccinate synthetases from various sources.
Clark SW; Berry SA; Ewing R; Rudolph FB
Comp Biochem Physiol B; 1977; 58(1):63-5. PubMed ID: 318261
[TBL] [Abstract][Full Text] [Related]
59. Purine metabolic cycle in normal and leukemic leukocytes.
Dietz AA; Czebotar V
Cancer Res; 1977 Feb; 37(2):419-26. PubMed ID: 188545
[TBL] [Abstract][Full Text] [Related]
60. Determination of 5'-nucleotidase activity in healthy and leukemic lymphocytes.
Rosi F; Agostinho AB; Carlucci F; Galieni P; Leoncini R; Pizzichini M; Tabucchi A; Pagani R; Dispensa E
Biochem Soc Trans; 1993 Nov; 21(4):477S. PubMed ID: 8132044
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
